Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy

Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials science Vol. 11; no. 21; pp. 7132 - 7145
Main Authors Zhu, Fukai, Huang, Cailin, Lin, YanLing, Li, Yang, Tu, Ruiqin, Lu, Weihong
Format Journal Article
LanguageEnglish
Published Cambridge Royal Society of Chemistry 24.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug via Cu( ii ) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu( ii ) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The in vivo experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics. A GSH-responsive Cu( ii )-coordinated anti-angiogenic nanodrug was developed by the metal-coordination-driven assembly of an anti-angiogenic drug and photosensitizer for synergistic chemo-phototherapy with GSH depletion.
AbstractList Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug via Cu( ii ) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu( ii ) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The in vivo experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics.
Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug via Cu(ii) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu(ii) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The in vivo experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics.
Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug via Cu( ii ) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu( ii ) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The in vivo experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics. A GSH-responsive Cu( ii )-coordinated anti-angiogenic nanodrug was developed by the metal-coordination-driven assembly of an anti-angiogenic drug and photosensitizer for synergistic chemo-phototherapy with GSH depletion.
Author Lu, Weihong
Lin, YanLing
Li, Yang
Huang, Cailin
Zhu, Fukai
Tu, Ruiqin
AuthorAffiliation Minnan Normal University
Chinese Academy of Sciences
Department of Gynecology
Zhongshan Hospital
Department of Obstetrics and Gynecology
Department of Translational Medicine & Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials
Haixi Institute
Xiamen Institute of Rare-Earth Materials
Engineering Technological Center of Mushroom Industry
Zhongshan Hospital (Xiamen)
Xiamen Clinical Research Center for Cancer Therapy
Fudan University
CAS Key Laboratory of Design and Assembly of Functional Nanostructures
Fujian Institute of Research on the Structure of Matter
AuthorAffiliation_xml – name: Chinese Academy of Sciences
– name: Xiamen Clinical Research Center for Cancer Therapy
– name: Minnan Normal University
– name: Department of Gynecology
– name: Engineering Technological Center of Mushroom Industry
– name: Department of Obstetrics and Gynecology
– name: Xiamen Institute of Rare-Earth Materials
– name: Haixi Institute
– name: Fudan University
– name: CAS Key Laboratory of Design and Assembly of Functional Nanostructures
– name: Zhongshan Hospital
– name: Zhongshan Hospital (Xiamen)
– name: Fujian Institute of Research on the Structure of Matter
– name: Department of Translational Medicine & Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials
Author_xml – sequence: 1
  givenname: Fukai
  surname: Zhu
  fullname: Zhu, Fukai
– sequence: 2
  givenname: Cailin
  surname: Huang
  fullname: Huang, Cailin
– sequence: 3
  givenname: YanLing
  surname: Lin
  fullname: Lin, YanLing
– sequence: 4
  givenname: Yang
  surname: Li
  fullname: Li, Yang
– sequence: 5
  givenname: Ruiqin
  surname: Tu
  fullname: Tu, Ruiqin
– sequence: 6
  givenname: Weihong
  surname: Lu
  fullname: Lu, Weihong
BookMark eNpd0c9L5TAQB_AgLvhjvXgXAl5EqDtt0ub16M_ngsse1HNJk0lfpE1qkqeU_eetPlHYucwcPjMMfPfItvMOCTnM4SwHVv_SrB0A6pp3W2S3AC4yvuD19tfMYIccxPgEcwlRQ5Xvkn_32JtMY29fMEzUGyrpgEn2mfI-aOtkQk2lSzaTrrO-Q2cVddJ5HdYdfbVpRZf3t1Tj2GOyrqOytb1NEzU-0Dg5DJ2Nad5RKxx8Nq588mmFQY7TT_LDyD7iwWffJ4831w-Xt9nd3-Xvy_O7TLGcp0xWQoDS3LRSCQ1QaMlKjWWRFwx13bJai6IqlCmNAtWiWXCBrColayssoGL75GRzdwz-eY0xNYONCvteOvTr2BSLitcAZS5mevwfffLr4ObvZrUAwQWUfFanG6WCjzGgacZgBxmmJofmPYrmil38-YhiOeOjDQ5RfbnvqNgb8G-JWQ
CitedBy_id crossref_primary_10_1016_j_ejpb_2024_114348
Cites_doi 10.1016/j.ccr.2021.213828
10.1016/j.cclet.2021.07.041
10.1038/s41571-022-00699-x
10.1002/adma.201707567
10.1016/j.jconrel.2020.10.014
10.1038/s41392-022-01231-4
10.1021/acsnano.1c09171
10.1038/s41591-019-0358-x
10.1016/j.cej.2022.140892
10.1016/j.taap.2019.114785
10.1016/j.pmatsci.2021.100919
10.1002/EXP.20210238
10.1021/acs.nanolett.9b05008
10.1038/s41573-022-00615-z
10.1166/jbn.2012.1398
10.1002/adfm.202206157
10.1016/j.jpha.2022.12.002
10.1038/s41467-023-37315-0
10.1039/D0TB00850H
10.1002/advs.202101101
10.1016/j.jconrel.2020.02.025
10.3390/molecules16097880
10.1016/j.phrs.2022.106487
10.1182/blood-2006-10-050807
10.1021/jacs.1c03788
10.1016/j.nantod.2020.100946
10.7150/thno.46728
10.4155/ppa-2017-0035
10.3390/molecules24112162
10.1021/acs.chemrev.0c00977
10.1038/s41467-018-03473-9
10.1126/sciadv.aay9035
10.1038/nrclinonc.2017.44
10.1016/j.ejmech.2020.112081
10.1021/acsnano.6b04695
10.1016/j.apsb.2022.02.027
10.1038/emm.2007.78
10.1021/acsnano.9b05425
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2023
Copyright_xml – notice: Copyright Royal Society of Chemistry 2023
DBID AAYXX
CITATION
7SR
8BQ
8FD
JG9
7X8
DOI 10.1039/d3bm00994g
DatabaseName CrossRef
Engineered Materials Abstracts
METADEX
Technology Research Database
Materials Research Database
MEDLINE - Academic
DatabaseTitle CrossRef
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
METADEX
MEDLINE - Academic
DatabaseTitleList CrossRef
Materials Research Database

DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2047-4849
EndPage 7145
ExternalDocumentID 10_1039_D3BM00994G
d3bm00994g
GroupedDBID -JG
0-7
0R~
4.4
53G
705
AAEMU
AAGNR
AAIWI
AANOJ
ABASK
ABDVN
ABGFH
ABRYZ
ACGFS
ACIWK
ACLDK
ADMRA
AENEX
AETIL
AFOGI
AFVBQ
AGRSR
AGSTE
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANUXI
ASKNT
AUDPV
BLAPV
BSQNT
C6K
EBS
ECGLT
EE0
EF-
H13
HZ~
H~N
J3I
O-G
O9-
OK1
RAOCF
RCNCU
RPMJG
RRC
RSCEA
RVUXY
AAHBH
AAJAE
AARTK
AAWGC
AAXHV
AAYXX
ABEMK
ABJNI
ABPDG
ABXOH
ADSRN
AEFDR
AENGV
AESAV
AFLYV
AGEGJ
AHGCF
APEMP
CITATION
GGIMP
7SR
8BQ
8FD
JG9
7X8
ID FETCH-LOGICAL-c314t-a6770cd4fbac7d002da35de52123ed9b39d7262cf5fc0cbef847e365a3b6e2063
ISSN 2047-4830
IngestDate Fri Oct 25 01:06:17 EDT 2024
Thu Oct 10 17:04:34 EDT 2024
Fri Aug 23 01:01:49 EDT 2024
Wed Oct 25 11:00:57 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 21
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c314t-a6770cd4fbac7d002da35de52123ed9b39d7262cf5fc0cbef847e365a3b6e2063
Notes https://doi.org/10.1039/d3bm00994g
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8950-1212
PQID 2880747054
PQPubID 2047520
PageCount 14
ParticipantIDs rsc_primary_d3bm00994g
proquest_journals_2880747054
proquest_miscellaneous_2864900517
crossref_primary_10_1039_D3BM00994G
PublicationCentury 2000
PublicationDate 2023-10-24
PublicationDateYYYYMMDD 2023-10-24
PublicationDate_xml – month: 10
  year: 2023
  text: 2023-10-24
  day: 24
PublicationDecade 2020
PublicationPlace Cambridge
PublicationPlace_xml – name: Cambridge
PublicationTitle Biomaterials science
PublicationYear 2023
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
References Yadav (D3BM00994G/cit9/1) 2018; 7
Zhong (D3BM00994G/cit29/1) 2021; 437
Peng (D3BM00994G/cit11/1) 2012; 8
Liu (D3BM00994G/cit33/1) 2023; 456
Fang (D3BM00994G/cit21/1) 2023; 14
Yang (D3BM00994G/cit38/1) 2021; 143
Ben-Akiva (D3BM00994G/cit28/1) 2020; 6
Luo (D3BM00994G/cit6/1) 2022; 9
Shan (D3BM00994G/cit20/1) 2018; 30
Li (D3BM00994G/cit26/1) 2019; 13
Feng (D3BM00994G/cit4/1) 2019; 25
Song (D3BM00994G/cit10/1) 2011; 16
Karaosmanoglu (D3BM00994G/cit24/1) 2021; 329
Sethi (D3BM00994G/cit7/1) 2007; 109
Ye (D3BM00994G/cit35/1) 2022; 32
Chen (D3BM00994G/cit2/1) 2022; 185
Chen (D3BM00994G/cit40/1) 2020; 10
Koo (D3BM00994G/cit34/1) 2022; 16
Wu (D3BM00994G/cit12/1) 2018; 10
Xiong (D3BM00994G/cit19/1) 2020; 20
Tu (D3BM00994G/cit18/1) 2020; 8
Jana (D3BM00994G/cit30/1) 2022; 2
Nam (D3BM00994G/cit17/1) 2018; 9
Wang (D3BM00994G/cit31/1) 2020; 35
Jin (D3BM00994G/cit1/1) 2023; 22
Jin (D3BM00994G/cit13/1) 2019; 24
Hou (D3BM00994G/cit15/1) 2020; 189
Li (D3BM00994G/cit25/1) 2020; 321
Shibue (D3BM00994G/cit16/1) 2017; 14
Liu (D3BM00994G/cit23/1) 2022; 125
Xu (D3BM00994G/cit32/1) 2021; 8
Hong (D3BM00994G/cit3/1) 2023; 13
Jung (D3BM00994G/cit8/1) 2007; 39
Chen (D3BM00994G/cit39/1) 2016; 10
Chen (D3BM00994G/cit22/1) 2022; 12
Xu (D3BM00994G/cit5/1) 2023; 8
Fang (D3BM00994G/cit27/1) 2023; 20
Xu (D3BM00994G/cit37/1) 2022; 33
Liu (D3BM00994G/cit14/1) 2019; 383
Tang (D3BM00994G/cit36/1) 2021; 121
References_xml – volume: 437
  start-page: 213828
  year: 2021
  ident: D3BM00994G/cit29/1
  publication-title: Coord. Chem. Rev.
  doi: 10.1016/j.ccr.2021.213828
  contributor:
    fullname: Zhong
– volume: 33
  start-page: 968
  year: 2022
  ident: D3BM00994G/cit37/1
  publication-title: Chin. Chem. Lett.
  doi: 10.1016/j.cclet.2021.07.041
  contributor:
    fullname: Xu
– volume: 20
  start-page: 33
  year: 2023
  ident: D3BM00994G/cit27/1
  publication-title: Nat. Rev. Clin Oncol.
  doi: 10.1038/s41571-022-00699-x
  contributor:
    fullname: Fang
– volume: 30
  start-page: 1707567
  year: 2018
  ident: D3BM00994G/cit20/1
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201707567
  contributor:
    fullname: Shan
– volume: 329
  start-page: 805
  year: 2021
  ident: D3BM00994G/cit24/1
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2020.10.014
  contributor:
    fullname: Karaosmanoglu
– volume: 8
  start-page: 51
  year: 2023
  ident: D3BM00994G/cit5/1
  publication-title: Signal Transduction Targeted Ther.
  doi: 10.1038/s41392-022-01231-4
  contributor:
    fullname: Xu
– volume: 9
  start-page: 22
  year: 2022
  ident: D3BM00994G/cit6/1
  publication-title: Mil. Med. Res.
  contributor:
    fullname: Luo
– volume: 16
  start-page: 2535
  year: 2022
  ident: D3BM00994G/cit34/1
  publication-title: ACS Nano
  doi: 10.1021/acsnano.1c09171
  contributor:
    fullname: Koo
– volume: 25
  start-page: 575
  year: 2019
  ident: D3BM00994G/cit4/1
  publication-title: Nat. Med.
  doi: 10.1038/s41591-019-0358-x
  contributor:
    fullname: Feng
– volume: 456
  start-page: 140892
  year: 2023
  ident: D3BM00994G/cit33/1
  publication-title: Chem. Eng. J.
  doi: 10.1016/j.cej.2022.140892
  contributor:
    fullname: Liu
– volume: 383
  start-page: 114785
  year: 2019
  ident: D3BM00994G/cit14/1
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2019.114785
  contributor:
    fullname: Liu
– volume: 125
  start-page: 100919
  year: 2022
  ident: D3BM00994G/cit23/1
  publication-title: Prog. Mater. Sci.
  doi: 10.1016/j.pmatsci.2021.100919
  contributor:
    fullname: Liu
– volume: 2
  start-page: 20210238
  year: 2022
  ident: D3BM00994G/cit30/1
  publication-title: Exploration
  doi: 10.1002/EXP.20210238
  contributor:
    fullname: Jana
– volume: 20
  start-page: 1781
  year: 2020
  ident: D3BM00994G/cit19/1
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.9b05008
  contributor:
    fullname: Xiong
– volume: 22
  start-page: 213
  year: 2023
  ident: D3BM00994G/cit1/1
  publication-title: Nat. Rev. Drug Discovery
  doi: 10.1038/s41573-022-00615-z
  contributor:
    fullname: Jin
– volume: 8
  start-page: 491
  year: 2012
  ident: D3BM00994G/cit11/1
  publication-title: J. Biomed. Nanotechnol.
  doi: 10.1166/jbn.2012.1398
  contributor:
    fullname: Peng
– volume: 32
  start-page: 2206157
  year: 2022
  ident: D3BM00994G/cit35/1
  publication-title: Adv. Funct. Mater.
  doi: 10.1002/adfm.202206157
  contributor:
    fullname: Ye
– volume: 13
  start-page: 156
  year: 2023
  ident: D3BM00994G/cit3/1
  publication-title: J. Pharm. Anal.
  doi: 10.1016/j.jpha.2022.12.002
  contributor:
    fullname: Hong
– volume: 14
  start-page: 1660
  year: 2023
  ident: D3BM00994G/cit21/1
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-023-37315-0
  contributor:
    fullname: Fang
– volume: 8
  start-page: 5667
  year: 2020
  ident: D3BM00994G/cit18/1
  publication-title: J. Mater. Chem. B
  doi: 10.1039/D0TB00850H
  contributor:
    fullname: Tu
– volume: 8
  start-page: 2101101
  year: 2021
  ident: D3BM00994G/cit32/1
  publication-title: Adv. Sci.
  doi: 10.1002/advs.202101101
  contributor:
    fullname: Xu
– volume: 321
  start-page: 222
  year: 2020
  ident: D3BM00994G/cit25/1
  publication-title: J. Controlled Release
  doi: 10.1016/j.jconrel.2020.02.025
  contributor:
    fullname: Li
– volume: 16
  start-page: 7880
  year: 2011
  ident: D3BM00994G/cit10/1
  publication-title: Molecules
  doi: 10.3390/molecules16097880
  contributor:
    fullname: Song
– volume: 185
  start-page: 106487
  year: 2022
  ident: D3BM00994G/cit2/1
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2022.106487
  contributor:
    fullname: Chen
– volume: 109
  start-page: 2727
  year: 2007
  ident: D3BM00994G/cit7/1
  publication-title: Blood
  doi: 10.1182/blood-2006-10-050807
  contributor:
    fullname: Sethi
– volume: 143
  start-page: 14530
  year: 2021
  ident: D3BM00994G/cit38/1
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.1c03788
  contributor:
    fullname: Yang
– volume: 35
  start-page: 100946
  year: 2020
  ident: D3BM00994G/cit31/1
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2020.100946
  contributor:
    fullname: Wang
– volume: 10
  start-page: 10290
  year: 2020
  ident: D3BM00994G/cit40/1
  publication-title: Theranostics
  doi: 10.7150/thno.46728
  contributor:
    fullname: Chen
– volume: 7
  start-page: 155
  year: 2018
  ident: D3BM00994G/cit9/1
  publication-title: Pharm. Pat. Anal.
  doi: 10.4155/ppa-2017-0035
  contributor:
    fullname: Yadav
– volume: 24
  start-page: 2162
  year: 2019
  ident: D3BM00994G/cit13/1
  publication-title: Molecules
  doi: 10.3390/molecules24112162
  contributor:
    fullname: Jin
– volume: 121
  start-page: 1981
  year: 2021
  ident: D3BM00994G/cit36/1
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.0c00977
  contributor:
    fullname: Tang
– volume: 9
  start-page: 1074
  year: 2018
  ident: D3BM00994G/cit17/1
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03473-9
  contributor:
    fullname: Nam
– volume: 6
  start-page: eaay9035
  year: 2020
  ident: D3BM00994G/cit28/1
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aay9035
  contributor:
    fullname: Ben-Akiva
– volume: 10
  start-page: 2078
  year: 2018
  ident: D3BM00994G/cit12/1
  publication-title: Am. J. Transl. Res.
  contributor:
    fullname: Wu
– volume: 14
  start-page: 611
  year: 2017
  ident: D3BM00994G/cit16/1
  publication-title: Nat. Rev. Clin Oncol.
  doi: 10.1038/nrclinonc.2017.44
  contributor:
    fullname: Shibue
– volume: 189
  start-page: 112081
  year: 2020
  ident: D3BM00994G/cit15/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2020.112081
  contributor:
    fullname: Hou
– volume: 10
  start-page: 10049
  year: 2016
  ident: D3BM00994G/cit39/1
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b04695
  contributor:
    fullname: Chen
– volume: 12
  start-page: 3710
  year: 2022
  ident: D3BM00994G/cit22/1
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2022.02.027
  contributor:
    fullname: Chen
– volume: 39
  start-page: 715
  year: 2007
  ident: D3BM00994G/cit8/1
  publication-title: Exp. Mol. Med.
  doi: 10.1038/emm.2007.78
  contributor:
    fullname: Jung
– volume: 13
  start-page: 12912
  year: 2019
  ident: D3BM00994G/cit26/1
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b05425
  contributor:
    fullname: Li
SSID ssj0000779061
Score 2.3628252
Snippet Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of...
SourceID proquest
crossref
rsc
SourceType Aggregation Database
Publisher
StartPage 7132
SubjectTerms Antiangiogenics
Biocompatibility
Biomimetics
Coordination
Depletion
Inorganic materials
Light therapy
Radiation damage
Scavenging
Self-assembly
Toxicity
Tumors
Title Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy
URI https://www.proquest.com/docview/2880747054
https://search.proquest.com/docview/2864900517
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZoe4ED4lURKMgIbpHLxt6Xj6WkDSgthyZSOK382nRFs1ulyaHw5xl7vbsp4VC4rCIn8SqeL-NvxjPfIvQh4CaluUyI1KkiIRBckoaGE5pzanjAKRU2D3l2Ho-m4ddZNOvKbV13yUoeqp9_7Sv5H6vCGNjVdsn-g2XbSWEAXoN94QoWhuu9bHxhrnKizZWtrbitOx0XBtg0URXElEUpLJ2EpSuIKOdFBfMUql-KstLLtU_Bnl6MbDWsk-Ce92vR7rqG8-bWtgU6Hec-WHZRkevLauUbtu4eBhcV8N76B_f9ltolpNeOH69_iKKDkE9SHwu4XVcTVMsZfBfluNlP3agfnG8mKKgrdav7og-Nc2TUqkGEaS1N2nrdwQa66iZp70MhbKYb-3EyqPUmt3x9wKxUqmZyYWluOO92tOYU__xbdjIdj7PJcDbZQXsUfBE4wb2j4eTLuE3EBVZxMR400rWMf-ymvEtWughkZ9k8HsbRkMkT9NjHD_ioBsNT9MCUz9CjDVXJ5-jXHVjgKscCb8EC_wEL3MACW1hggAVuYYE9LDDAAm_AAm_D4gWangwnxyPin7FBFBuEKyLiJAmUDnMpVKJhe9SCRdq4jm6juWRcJzSmKo9yFShpcmAzhsWRYDI2FPjtPtotq9K8RDhUsdZpCIw_gqDWSMkjFuURjZVJKNWyh943i5ld11IqmSuBYDz7zD6duSU_7aGDZp0z_1e7yWhqNZsSCC966F37NjhCe7olSlOt7WfikDvJuR7aB_u09-jM-eoeX36NHnYgPkC7q-XavAHeuZJvPXJ-AxcFjDU
link.rule.ids 315,783,787,27936,27937
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Self-delivery+of+a+metal-coordinated+anti-angiogenic+nanodrug+with+GSH+depleting+ability+for+synergistic+chemo-phototherapy&rft.jtitle=Biomaterials+science&rft.au=Zhu%2C+Fukai&rft.au=Huang%2C+Cailin&rft.au=Lin%2C+YanLing&rft.au=Li%2C+Yang&rft.date=2023-10-24&rft.eissn=2047-4849&rft.volume=11&rft.issue=21&rft.spage=7132&rft.epage=7145&rft_id=info:doi/10.1039%2Fd3bm00994g&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-4830&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-4830&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-4830&client=summon